Sign inGet started

Horga Maria Arantxa

Insider CIK 1829614 · AVIR Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AVIR Atea Pharmaceuticals, Inc. A Award deriv2026-01-312026-02-03173,500— $0173,500SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise deriv2026-01-312026-02-039,750— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise deriv2026-01-312026-02-0341,533— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise2026-01-312026-02-0351,283— $0112,159SEC↗
AVIR Atea Pharmaceuticals, Inc. F Tax w/h2026-01-312026-02-0316,073$4.24 $68.1K96,086SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise deriv2025-01-312025-02-0441,533— $041,533SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2025-01-312025-02-04192,800— $0192,800SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2025-01-312025-02-049,750— $09,750SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise2025-01-312025-02-0441,533— $067,197SEC↗
AVIR Atea Pharmaceuticals, Inc. F Tax w/h2025-01-312025-02-0416,071$3.06 $49.2K60,876SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award2025-01-312025-02-049,750— $076,947SEC↗
AVIR Atea Pharmaceuticals, Inc. S Sale2024-02-012024-02-0215,870$3.84 $60.9K25,664SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2024-01-312024-02-02192,800— $0192,800SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise deriv2024-01-312024-02-0241,534— $083,066SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise2024-01-312024-02-0241,534— $041,534SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2023-01-312023-02-02174,500— $0174,500SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2023-01-312023-02-02124,600— $0124,600SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2022-01-312022-02-02170,000— $0170,000SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2021-01-292021-02-01145,500— $0145,500SEC↗